Home About us Contact | |||
Fluorescein Leakage (fluorescein + leakage)
Selected AbstractsFluorescein leakage of the optic disc: time course in primary open-angle glaucomaOPHTHALMIC AND PHYSIOLOGICAL OPTICS, Issue 3 2010Niklas Plange Abstract Purpose:, To identify and quantify the time course of fluorescein leakage of the optic nerve head in primary open-angle glaucoma (POAG) and controls. Methods:, Twenty patients with POAG (aged 58 ± 10 years) and 14 controls (aged 51 ± 12 years, p = 0.07) were included in a prospective study. Fluorescein leakage of the optic disc was quantified using digital image analysis. A new leakage ratio (fluorescence of the optic disc divided by fluorescence of the surrounding retina) was defined and fluorescein leakage was quantified at 7,8, 9,10, 11,12, and 13,14 min after injection of 2.5 cc sodium fluorescein (10%). Results:, The fluorescein leakage exhibited a significantly different time course with higher leakage ratio values in POAG compared to controls (7,8 min: 1.24 ± 0.32 vs 1.16 ± 0.12; 9,10 min: 1.37 ± 0.37 vs 1.19 ± 0.1; 11,12 min: 1.38 ± 0.36 vs 1.24 ± 0.13; 13,14 min: 1.44 ± 0.36 vs 1.27 ± 0.13; p = 0.004). The change in optic disc fluorescence from 7,8 min to 9,10 min was significantly higher in POAG compared to controls (0.13 ± 0.09 vs 0.03 ± 0.07; p = 0.002). Conclusion:, The time course of fluorescein leakage is significantly different in POAG compared to controls. This might reflect damage of the optic disc vasculature related to increased vascular permeability. [source] Tolerance and safety of ocular use of recombinant human erythropoietin (rhEPO).ACTA OPHTHALMOLOGICA, Issue 2009Neuroprotective effects in ocular hypertension/glaucoma Purpose The purpose of this study was to evaluate the long-term effects of monthly intravitreal injections of rhEPO in a rabbit model. Methods Sixteen New Zealand rabbits were divided into 4 groups: control (no injection), saline injection, or rhEPO injections of 500 U and 1000 U (N=4 per group). The right eye of each animal was injected monthly over a period of 7 months. Fundus examination and electroretinography (ERG) were performed at 1 day prior, and 1 week, 1 month, and 6 months after the initial injection. After the final ERG, animals underwent fluorescein angiography and sacrifice one week later. Scotopic and photopic ERG amplitude and implicit times were analyzed by calculating a ratio between the right and the left eyes. Angiograms were graded for the presence of neovascularization or leakage. Statistical analysis was carried out using two-way ANOVA. Results Fifteen animals were used for this experiment (1 developed a traumatic cataract and was excluded). Between all groups and time points, there were no statistically significant differences in the computed right eye:left eye ratios for the scotopic or photopic ERG components (p>0.05). No evidence of neovascularization or fluorescein leakage was seen on angiography. There were no visible differences in retinal architecture or thickness in the rhEPO groups when compared to uninjected controls. Conclusion Monthly 0.1 ml intravitreal injections of rhEPO at a dose of up to 1000 U over 7 months is well-tolerated and does not cause adverse effects on retinal function, architecture, or vasculature in a rabbit model. A review of published data on rhEPO and Glaucoma will also be presented. [source] High-definition Fourier domain OCT: non-invasive assessment of BRB changesACTA OPHTHALMOLOGICA, Issue 2009R BERNARDES Purpose To demonstrate the possibility of using a non-invasive imaging technique, the high-definition spectral domain optical coherence tomography, as a surrogate detector of blood-retinal barrier (BRB) breakdown. Methods Healthy volunteers and diabetic patients with diabetic retinopathy, age- related macular degeneration, choroidal neo-vascularisation and cystoid macular edema, underwent optical coherence tomography by Cirrus HD-OCT (Carl Zeiss Meditec, Dublin, CA, USA). Profiles of reflectivity distribution between the inner-limiting membrane and the retinal pigment epithelium were built, normalized, aligned and compared. Patients underwent retinal leakage analyzer (RLA) to identify areas of retinal fluorescein leakage into the vitreous as areas of blood-retinal barrier breakdown. Results The comparison between healthy volunteers' and patients' reflectivity distribution demonstrates these profiles differ. Moreover, when comparing reflectivity distribution within the same eye between areas of leakage and areas of non-leakage, the sum of the squared differences is over one decade relatively to the comparison between two similar areas (leakage/leakage or non-leakage/non-leakage). Conclusion These findings suggest that high-definition OCT may be useful in identifying areas of retinal leakage/BRB breakdown and therefore to be used as surrogate for fluorescein angiography and retinal leakage analyzer. [source] |